Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.480
+0.300 (13.76%)
At close: Jun 6, 2025, 4:00 PM
2.490
+0.010 (0.40%)
After-hours: Jun 6, 2025, 7:42 PM EDT

Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $125.84 million. The enterprise value is $22.81 million.

Market Cap 125.84M
Enterprise Value 22.81M

Important Dates

The last earnings date was Thursday, May 15, 2025, before market open.

Earnings Date May 15, 2025
Ex-Dividend Date n/a

Share Statistics

Cabaletta Bio has 50.74 million shares outstanding. The number of shares has increased by 11.24% in one year.

Current Share Class 50.74M
Shares Outstanding 50.74M
Shares Change (YoY) +11.24%
Shares Change (QoQ) +1.22%
Owned by Insiders (%) 2.98%
Owned by Institutions (%) 60.52%
Float 43.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.04
P/TBV Ratio 1.04
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.96, with a Debt / Equity ratio of 0.24.

Current Ratio 3.96
Quick Ratio 3.88
Debt / Equity 0.24
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -128.83

Financial Efficiency

Return on equity (ROE) is -73.85% and return on invested capital (ROIC) is -44.13%.

Return on Equity (ROE) -73.85%
Return on Assets (ROA) -41.37%
Return on Invested Capital (ROIC) -44.13%
Return on Capital Employed (ROCE) -102.36%
Revenue Per Employee n/a
Profits Per Employee -$772,927
Employee Count 164
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.80% in the last 52 weeks. The beta is 2.79, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y) 2.79
52-Week Price Change -77.80%
50-Day Moving Average 1.47
200-Day Moving Average 2.80
Relative Strength Index (RSI) 77.38
Average Volume (20 Days) 2,656,444

Short Selling Information

The latest short interest is 5.52 million, so 10.89% of the outstanding shares have been sold short.

Short Interest 5.52M
Short Previous Month 6.10M
Short % of Shares Out 10.89%
Short % of Float 12.72%
Short Ratio (days to cover) 4.64

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -134.25M
Pretax Income -89.98M
Net Income -126.76M
EBITDA -132.44M
EBIT -134.25M
Earnings Per Share (EPS) -$2.57
Full Income Statement

Balance Sheet

The company has $131.83 million in cash and $28.79 million in debt, giving a net cash position of $103.04 million or $2.03 per share.

Cash & Cash Equivalents 131.83M
Total Debt 28.79M
Net Cash 103.04M
Net Cash Per Share $2.03
Equity (Book Value) 121.55M
Book Value Per Share 2.40
Working Capital 100.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$95.04 million and capital expenditures -$2.18 million, giving a free cash flow of -$97.22 million.

Operating Cash Flow -95.04M
Capital Expenditures -2.18M
Free Cash Flow -97.22M
FCF Per Share -$1.92
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.24%
Shareholder Yield -11.24%
Earnings Yield -100.73%
FCF Yield -77.26%

Analyst Forecast

The average price target for Cabaletta Bio is $20.33, which is 719.76% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.33
Price Target Difference 719.76%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -8.98%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1